RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis

PURPOSE: The mode of action of targeted cancer agents (TCAs) differs from classic chemotherapy, which leads to concerns about the role of RECIST in evaluating tumor response in trials with TCAs. We investigated the performance of RECIST using a pooled database from 50 clinical trials with at least o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Litière, Saskia, Isaac, Gaëlle, De Vries, Elisabeth G.E., Bogaerts, Jan, Chen, Alice, Dancey, Janet, Ford, Robert, Gwyther, Stephen, Hoekstra, Otto, Huang, Erich, Lin, Nancy, Liu, Yan, Mandrekar, Sumithra, Schwartz, Lawrence H., Shankar, Lalitha, Therasse, Patrick, Seymour, Lesley
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2019
Aiheet:
ORIGINAL REPORTS
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494357/
https://ncbi.nlm.nih.gov/pubmed/30860949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01100
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia